This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, N.
Right arrow Articles by Takada, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, N.
Right arrow Articles by Takada, K.

 Previous Article  |  Next Article 

J. Virol., 10 1996, 7260-7263, Vol 70, No. 10
Copyright © 1996, American Society for Microbiology

Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV- negative Akata cells

N Shimizu, H Yoshiyama and K Takada
Department of Virology and Parasitology, Yamaguchi University School of Medicine, Japan.

We lack a host cell supporting an efficient lytic replication of Epstein-Barr virus (EBV). Recently, we isolated EBV-negative cell clones from the Akata cell line (referred as Akata- [N. Shimizu, A. Tanabe-Tochikura, Y. Kuroiwa, and K. Takada, J. Virol. 68:6069-6073, 1994). Since the parental Akata line is one of the highest EBV producers, we examined whether Akata- cells had become a good host for EBV propagation. The parental Akata cells have about 20 copies of EBV plasmid per cell. A drug resistance gene was inserted into one of them by homologous recombination. The resultant virus preparation, a mixture of wild-type and recombinant EBV, was used to infect Akata- cells. After incubation in the selective medium, drug-resistant Akata- cell clones were isolated and proved to be infected with recombinant EBV only. By treatment of the cells with antiimmunoglobulin antibodies, a large amount of recombinant EBV (i.e., more than 10 microg/1-liter culture) was produced. In contrast, three other B-lymphoma lines, BJAB, Ramos, and Louckes, were nonpermissive for virus replication. These results indicate that Akata- cells are suitable for propagation of recombinant EBV clonally, which becomes a powerful tool for determining EBV genetics and which makes it possible to use EBV as a vector for gene therapy.


This article has been cited by other articles:

  • Katsumura, K. R., Maruo, S., Wu, Y., Kanda, T., Takada, K. (2009). Quantitative evaluation of the role of Epstein-Barr virus immediate-early protein BZLF1 in B-cell transformation. J. Gen. Virol. 90: 2331-2341 [Abstract] [Full Text]  
  • Iwakiri, D., Zhou, L., Samanta, M., Matsumoto, M., Ebihara, T., Seya, T., Imai, S., Fujieda, M., Kawa, K., Takada, K. (2009). Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3. JEM 206: 2091-2099 [Abstract] [Full Text]  
  • Ali, A. K. M., Saito, S., Shibata, S., Takada, K., Kanda, T. (2009). Distinctive Effects of the Epstein-Barr Virus Family of Repeats on Viral Latent Gene Promoter Activity and B-Lymphocyte Transformation. J. Virol. 83: 9163-9174 [Abstract] [Full Text]  
  • Tsai, S.-C., Lin, S.-J., Chen, P.-W., Luo, W.-Y., Yeh, T.-H., Wang, H.-W., Chen, C.-J., Tsai, C.-H. (2009). EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines. Blood 114: 109-118 [Abstract] [Full Text]  
  • Hino, R., Uozaki, H., Murakami, N., Ushiku, T., Shinozaki, A., Ishikawa, S., Morikawa, T., Nakaya, T., Sakatani, T., Takada, K., Fukayama, M. (2009). Activation of DNA Methyltransferase 1 by EBV Latent Membrane Protein 2A Leads to Promoter Hypermethylation of PTEN Gene in Gastric Carcinoma. Cancer Res. 69: 2766-2774 [Abstract] [Full Text]  
  • Hino, R., Uozaki, H., Inoue, Y., Shintani, Y., Ushiku, T., Sakatani, T., Takada, K., Fukayama, M. (2008). Survival Advantage of EBV-Associated Gastric Carcinoma: Survivin Up-regulation by Viral Latent Membrane Protein 2A. Cancer Res. 68: 1427-1435 [Abstract] [Full Text]  
  • Seto, E., Ooka, T., Middeldorp, J., Takada, K. (2008). Reconstitution of Nasopharyngeal Carcinoma-Type EBV Infection Induces Tumorigenicity. Cancer Res. 68: 1030-1036 [Abstract] [Full Text]  
  • Flavell, J. R., Baumforth, K. R. N., Wood, V. H. J., Davies, G. L., Wei, W., Reynolds, G. M., Morgan, S., Boyce, A., Kelly, G. L., Young, L. S., Murray, P. G. (2008). Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood 111: 292-301 [Abstract] [Full Text]  
  • Wu, Y., Maruo, S., Yajima, M., Kanda, T., Takada, K. (2007). Epstein-Barr Virus (EBV)-Encoded RNA 2 (EBER2) but Not EBER1 Plays a Critical Role in EBV-Induced B-Cell Growth Transformation. J. Virol. 81: 11236-11245 [Abstract] [Full Text]  
  • Lin, J.-H., Tsai, C.-H., Chu, J.-S., Chen, J.-Y., Takada, K., Shew, J.-Y. (2007). Dysregulation of HER2/HER3 Signaling Axis in Epstein-Barr Virus-Infected Breast Carcinoma Cells. J. Virol. 81: 5705-5713 [Abstract] [Full Text]  
  • Jones, R. J., Dickerson, S., Bhende, P. M., Delecluse, H.-J., Kenney, S. C. (2007). Epstein-Barr Virus Lytic Infection Induces Retinoic Acid-responsive Genes through Induction of a Retinol-metabolizing Enzyme, DHRS9. J. Biol. Chem. 282: 8317-8324 [Abstract] [Full Text]  
  • Baumforth, K. R. N., Flavell, J. R., Reynolds, G. M., Davies, G., Pettit, T. R., Wei, W., Morgan, S., Stankovic, T., Kishi, Y., Arai, H., Nowakova, M., Pratt, G., Aoki, J., Wakelam, M. J. O., Young, L. S., Murray, P. G. (2005). Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Blood 106: 2138-2146 [Abstract] [Full Text]  
  • Yajima, M., Kanda, T., Takada, K. (2005). Critical Role of Epstein-Barr Virus (EBV)-Encoded RNA in Efficient EBV-Induced B-Lymphocyte Growth Transformation. J. Virol. 79: 4298-4307 [Abstract] [Full Text]  
  • Ahsan, N., Kanda, T., Nagashima, K., Takada, K. (2005). Epstein-Barr Virus Transforming Protein LMP1 Plays a Critical Role in Virus Production. J. Virol. 79: 4415-4424 [Abstract] [Full Text]  
  • Stewart, S., Dawson, C. W., Takada, K., Curnow, J., Moody, C. A., Sixbey, J. W., Young, L. S. (2004). Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-{kappa}B transcription factor pathway. Proc. Natl. Acad. Sci. USA 101: 15730-15735 [Abstract] [Full Text]  
  • Yang, L., Hakoda, M., Iwabuchi, K., Takeda, T., Koike, T., Kamatani, N., Takada, K. (2004). Rheumatoid Factors Induce Signaling from B Cells, Leading to Epstein-Barr Virus and B-Cell Activation. J. Virol. 78: 9918-9923 [Abstract] [Full Text]  
  • Yang, L., Aozasa, K., Oshimi, K., Takada, K. (2004). Epstein-Barr Virus (EBV)-Encoded RNA Promotes Growth of EBV-Infected T Cells through Interleukin-9 Induction. Cancer Res. 64: 5332-5337 [Abstract] [Full Text]  
  • Kanda, T., Yajima, M., Ahsan, N., Tanaka, M., Takada, K. (2004). Production of High-Titer Epstein-Barr Virus Recombinants Derived from Akata Cells by Using a Bacterial Artificial Chromosome System. J. Virol. 78: 7004-7015 [Abstract] [Full Text]  
  • Wakisaka, N., Kondo, S., Yoshizaki, T., Murono, S., Furukawa, M., Pagano, J. S. (2004). Epstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Hypoxia-Inducible Factor 1{alpha}. Mol. Cell. Biol. 24: 5223-5234 [Abstract] [Full Text]  
  • Kanamori, M., Watanabe, S., Honma, R., Kuroda, M., Imai, S., Takada, K., Yamamoto, N., Nishiyama, Y., Kawaguchi, Y. (2004). Epstein-Barr Virus Nuclear Antigen Leader Protein Induces Expression of Thymus- and Activation-Regulated Chemokine in B Cells. J. Virol. 78: 3984-3993 [Abstract] [Full Text]  
  • Iwakiri, D., Takada, K. (2004). Phosphatidylinositol 3-Kinase Is a Determinant of Responsiveness to B Cell Antigen Receptor-Mediated Epstein-Barr Virus Activation. J. Immunol. 172: 1561-1566 [Abstract] [Full Text]  
  • Kennedy, G., Komano, J., Sugden, B. (2003). Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc. Natl. Acad. Sci. USA 100: 14269-14274 [Abstract] [Full Text]  
  • Iwakiri, D., Eizuru, Y., Tokunaga, M., Takada, K. (2003). Autocrine Growth of Epstein-Barr Virus-Positive Gastric Carcinoma Cells Mediated by an Epstein-Barr Virus-Encoded Small RNA. Cancer Res. 63: 7062-7067 [Abstract] [Full Text]  
  • Bonnet-Duquennoy, M., Haratech, A., Vandest, B., Lefeu, F., Joab, I. (2003). RESPONSE: Absence of the Epstein-Barr Virus Genome in Breast Cancer-Derived Cell Lines. JNCI J Natl Cancer Inst 95: 1254-1255 [Full Text]  
  • Kiss, C., Nishikawa, J., Takada, K., Trivedi, P., Klein, G., Szekely, L. (2003). T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus- carrying Burkitt lymphoma lines. Proc. Natl. Acad. Sci. USA 100: 4813-4818 [Abstract] [Full Text]  
  • Tune, C. E., Pilon, M., Saiki, Y., Dosch, H.-M. (2002). Sustained Expression of the Novel EBV-Induced Zinc Finger Gene, ZNFEB, Is Critical for the Transition of B Lymphocyte Activation to Oncogenic Growth Transformation. J. Immunol. 168: 680-688 [Abstract] [Full Text]  
  • Harris, R. S., Croom-Carter, D. S. G., Rickinson, A. B., Neuberger, M. S. (2001). Epstein-Barr Virus and the Somatic Hypermutation of Immunoglobulin Genes in Burkitt's Lymphoma Cells. J. Virol. 75: 10488-10492 [Abstract] [Full Text]  
  • Maruo, S., Yang, L., Takada, K. (2001). Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J. Gen. Virol. 82: 2373-2383 [Abstract] [Full Text]  
  • Konishi, K., Maruo, S., Kato, H., Takada, K. (2001). Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation. J. Gen. Virol. 82: 1451-1456 [Abstract] [Full Text]  
  • Trivedi, P., Spinsanti, P., Cuomo, L., Volpe, M., Takada, K., Frati, L., Faggioni, A. (2001). Differential Regulation of Epstein-Barr Virus (EBV) Latent Gene Expression in Burkitt Lymphoma Cells Infected with a Recombinant EBV Strain. J. Virol. 75: 4929-4935 [Abstract] [Full Text]  
  • Komano, J., Takada, K. (2001). Role of bcl-2 in Epstein-Barr Virus-Induced Malignant Conversion of Burkitt's Lymphoma Cell Line Akata. J. Virol. 75: 1561-1564 [Abstract] [Full Text]  
  • Yang, L., Maruo, S., Takada, K. (2000). CD21-Mediated Entry and Stable Infection by Epstein-Barr Virus in Canine and Rat Cells. J. Virol. 74: 10745-10751 [Abstract] [Full Text]  
  • Takada, K (2000). Epstein-Barr virus and gastric carcinoma. Mol. Pathol. 53: 255-261 [Abstract] [Full Text]  
  • Delecluse, H-J, Hammerschmidt, W (2000). The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy. Mol. Pathol. 53: 270-279 [Abstract] [Full Text]  
  • Molesworth, S. J., Lake, C. M., Borza, C. M., Turk, S. M., Hutt-Fletcher, L. M. (2000). Epstein-Barr Virus gH Is Essential for Penetration of B Cells but Also Plays a Role in Attachment of Virus to Epithelial Cells. J. Virol. 74: 6324-6332 [Abstract] [Full Text]  
  • Chang, Y., Tung, C.-H., Huang, Y.-T., Lu, J., Chen, J.-Y., Tsai, C.-H. (1999). Requirement for Cell-to-Cell Contact in Epstein-Barr Virus Infection of Nasopharyngeal Carcinoma Cells and Keratinocytes. J. Virol. 73: 8857-8866 [Abstract] [Full Text]  
  • Nishikawa, J., Imai, S., Oda, T., Kojima, T., Okita, K., Takada, K. (1999). Epstein-Barr Virus Promotes Epithelial Cell Growth in the Absence of EBNA2 and LMP1 Expression. J. Virol. 73: 1286-1292 [Abstract] [Full Text]  
  • Komano, J., Sugiura, M., Takada, K. (1998). Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt's Lymphoma Cell Line Akata. J. Virol. 72: 9150-9156 [Abstract] [Full Text]  
  • Borza, C. M., Hutt-Fletcher, L. M. (1998). Epstein-Barr Virus Recombinant Lacking Expression of Glycoprotein gp150 Infects B Cells Normally but Is Enhanced for Infection of Epithelial Cells. J. Virol. 72: 7577-7582 [Abstract] [Full Text]  
  • Imai, S., Nishikawa, J., Takada, K. (1998). Cell-to-Cell Contact as an Efficient Mode of Epstein-Barr Virus Infection of Diverse Human Epithelial Cells. J. Virol. 72: 4371-4378 [Abstract] [Full Text]  
  • Wang, X., Hutt-Fletcher, L. M. (1998). Epstein-Barr Virus Lacking Glycoprotein gp42 Can Bind to B Cells but Is Not Able To Infect. J. Virol. 72: 158-163 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»